Cargando…
A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners
BACKGROUND: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stab...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937313/ https://www.ncbi.nlm.nih.gov/pubmed/24586281 http://dx.doi.org/10.1371/journal.pone.0087564 |
_version_ | 1782305467783970816 |
---|---|
author | Yap, Lorraine Carruthers, Susan Thompson, Sandra Cheng, Wendy Jones, Jocelyn Simpson, Paul Richards, Alun Thein, Hla-Hla Haber, Paul Lloyd, Andrew Butler, Tony |
author_facet | Yap, Lorraine Carruthers, Susan Thompson, Sandra Cheng, Wendy Jones, Jocelyn Simpson, Paul Richards, Alun Thein, Hla-Hla Haber, Paul Lloyd, Andrew Butler, Tony |
author_sort | Yap, Lorraine |
collection | PubMed |
description | BACKGROUND: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations. METHOD AND FINDINGS: We undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners. CONCLUSION: This study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma. |
format | Online Article Text |
id | pubmed-3937313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39373132014-03-04 A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners Yap, Lorraine Carruthers, Susan Thompson, Sandra Cheng, Wendy Jones, Jocelyn Simpson, Paul Richards, Alun Thein, Hla-Hla Haber, Paul Lloyd, Andrew Butler, Tony PLoS One Research Article BACKGROUND: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations. METHOD AND FINDINGS: We undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners. CONCLUSION: This study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma. Public Library of Science 2014-02-27 /pmc/articles/PMC3937313/ /pubmed/24586281 http://dx.doi.org/10.1371/journal.pone.0087564 Text en © 2014 Yap et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Yap, Lorraine Carruthers, Susan Thompson, Sandra Cheng, Wendy Jones, Jocelyn Simpson, Paul Richards, Alun Thein, Hla-Hla Haber, Paul Lloyd, Andrew Butler, Tony A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners |
title | A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners |
title_full | A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners |
title_fullStr | A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners |
title_full_unstemmed | A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners |
title_short | A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners |
title_sort | descriptive model of patient readiness, motivators, and hepatitis c treatment uptake among australian prisoners |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937313/ https://www.ncbi.nlm.nih.gov/pubmed/24586281 http://dx.doi.org/10.1371/journal.pone.0087564 |
work_keys_str_mv | AT yaplorraine adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT carrutherssusan adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT thompsonsandra adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT chengwendy adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT jonesjocelyn adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT simpsonpaul adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT richardsalun adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT theinhlahla adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT haberpaul adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT lloydandrew adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT butlertony adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT yaplorraine descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT carrutherssusan descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT thompsonsandra descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT chengwendy descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT jonesjocelyn descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT simpsonpaul descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT richardsalun descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT theinhlahla descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT haberpaul descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT lloydandrew descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners AT butlertony descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners |